Drug Topics
JANUARY 10, 2023
Researchers at Cleveland Clinic evaluated whether a bivalent COVID-19 vaccine protects against both strains of the virus - the original virus strain and a component of the omicron variant.
Pharmacy Times
JANUARY 10, 2023
Patients with depression were significantly less likely to have adequate 12-month adherence to antiplatelets, β-blockers, and statins than those without depression.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 10, 2023
This eBook explores technology-based solutions for community pharmacies that simplify workflows for your revenue-driving services and automate mundane record-keeping tasks. Download it and make 2023 your year!
STAT
JANUARY 10, 2023
Mistakes happen — in life, in the lab, and, inevitably, in research papers, too. Journals use corrections and retractions to resolve those mistakes. But one particularly high-profile case is now drawing fresh attention to the problems with journals’ process for addressing concerns about research integrity. Late last year, Stanford University announced that it was opening an investigation into its president, neuroscientist Marc Tessier-Lavigne, over allegations of research misconduc
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JANUARY 10, 2023
Careful thought and adjustments are required to avoid exceeding the maximum recommended amount.
Pharmacy Times
JANUARY 10, 2023
The first episode of the Public Health Matters Video Series features Tom Frieden, MPH, MD, who discusses his background and influence on public health and national policy.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JANUARY 10, 2023
The Food and Drug Administration’s approach to evaluating some new medical devices might actually increase the risk that those devices will later be recalled over safety concerns. For some medical devices, the FDA requires data from studies in people to show that the device, including things like implantable heart defibrillators or stents, is safe and effective.
Drug Topics
JANUARY 10, 2023
Pharmacists can use a variety of tools to foster resilience and prevent burnout.
Pharmacy Times
JANUARY 10, 2023
Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.
pharmaphorum
JANUARY 10, 2023
mRNA specialist BioNTech has driven its partnership with UK artificial intelligence InstaDeep into top gear, agreeing to buy the company outright in a cash and equity deal that values it at up to £562 million ($683 million). The deal , billed as BioNTech’s largest to date and unveiled at the JP Morgan healthcare conference today, includes $362 million upfront with another £200 million on offer if performance targets are met.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JANUARY 10, 2023
The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.
Fierce Pharma
JANUARY 10, 2023
JPM23: Pfizer entering the 'most important' 18-month stretch in company history, CEO says. esagonowsky. Tue, 01/10/2023 - 08:51.
The FDA Law Blog
JANUARY 10, 2023
By Riëtte van Laack & Ricardo Carvajal — On Dec. 20, 2022, FTC announced the publication of its Health Products Compliance Guidance (“new Guidance”). FTC staff prepared the new Guidance to update and replace Dietary Supplements: An Advertising Guide for Industry , issued in 1998 (“1998 Guidance”). The new Guidance provides the first update in 25 years on FTC’s thinking regarding substantiation and disclosures for health-related claims.
Pharmacy Times
JANUARY 10, 2023
Individuals in metropolitan counties used mental health services more than individuals in rural counties.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
JANUARY 10, 2023
A study conducted by PharmaSmart found that 81% of users will share their validated PharmaSmart blood pressure readings with their pharmacist and 92% will share readings with their physician.
Fierce Healthcare
JANUARY 10, 2023
JPM23: CVS Health still weighing next steps as it plans foray into primary care. pminemyer. Tue, 01/10/2023 - 12:37.
Fierce Pharma
JANUARY 10, 2023
JPM23: Novavax hopes end of COVID emergency—and open vaccine market—will help it grow market share. aarmstrong. Tue, 01/10/2023 - 10:24.
pharmaphorum
JANUARY 10, 2023
Tuesday brings the on-site part of Fierce’s JPM event as well as day 2 of the Informa Biotech Showcase. We’ll do our best to surf between the two, as well as providing remote updates where we can from the main event. Fierce’s event “The long haul: How pharma and healthcare can survive in 2023” will feature guests from Bayer, Takeda, Genentech, and more.
Pharma Tutor
JANUARY 10, 2023
Lack of medicines in Greece and the solution of Generics. admin. Tue, 01/10/2023 - 15:46. Georgios-Marios Bolmpasis. MPharm Student University of Athens. Vice President of Pharmacy Students Association(Athens).
Fierce Healthcare
JANUARY 10, 2023
JPM23, Day 2: Cigna focusing on partnerships in primary care strategy; Omada, Intermountain launch partnership for diabetes care. hlandi. Tue, 01/10/2023 - 11:15.
pharmaphorum
JANUARY 10, 2023
Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues. Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets
Fierce Healthcare
JANUARY 10, 2023
LeanTaaS, Hospital IQ join forces to address hospital operational optimization. aburky. Tue, 01/10/2023 - 15:00.
Omnicell
JANUARY 10, 2023
Joy Somogyi Sr. Director Product Marketing & Development, Omnicell With drug costs skyrocketing and the ever-present challenge of drug shortages, throwing away medications can be agonizing. And costly. Expired medication waste has been estimated to cost the healthcare system $800 million a year. For example, one 240-bed facility valued its annual expired medication waste at $200K.
Pharmaceutical Technology
JANUARY 10, 2023
AstraZeneca has signed a definitive agreement to buy US-based biopharmaceutical company CinCor Pharma in a deal valued at about $1.8bn. Under the deal, the company will initiate a tender offer to purchase all the outstanding shares of CinCor Pharma for $26 per share in cash. The transaction also includes a non-tradable contingent value right of $10 per share in cash which will be paid after a specified regulatory submission of CinCor’s lead drug candidate, baxdrostat (CIN-107).
Omnicell
JANUARY 10, 2023
Carol Kimura VP, Brand, Digital, and Growth Marketing, Omnicell After 18 tumultuous months, we’re excited to finally return to our first live event! We’re in Las Vegas this week attending HIMSS21, meeting with chief innovation officers, chief technology officers, vice presidents of IT, and clinical leaders to showcase how the Autonomous Pharmacy supports this year’s conference theme: Be the Change.
Pharmacy Times
JANUARY 10, 2023
There are currently 33 RSV prevention candidates in clinical development using 6 different approaches.
Omnicell
JANUARY 10, 2023
Morgan Ledford Vice President, Talent Management, Omnicell Omnicell is looking for the best and brightest this summer with internship opportunities across North America. We want to give students a chance to build their professional experience while also creating a pipeline of incredible talent who can grow their careers at Omnicell and become our leaders of the future.
ISPE
JANUARY 10, 2023
The Aseptic Evolution from Manual Operations to Fully Automated Robotics Solutions. Trudy Patterson. Tue, 01/10/2023 - 12:15. iSpeak Blog. iSpeak. The Aseptic Evolution from Manual Operations to Fully Automated Robotics Solutions. Richard Denk. 10 January 2023. It has been a long journey from the development of primarily manual aseptic processes to fully automated systems that do not require manual intervention.
Omnicell
JANUARY 10, 2023
Len Hom Director, Product Marketing, Point of Care, Omnicell With billions spent on electronic health records (EHR), healthcare providers need other technology to integrate seamlessly with the EHR to create a more cohesive workflow. Simplifying medication retrieval allows nurses to focus on the patient, not the technology. When Omnicell partnered with Oracle Cerner for interoperability between the EHR and the XT Automated Dispensing System , the result was improved waste compliance, near 100 per
STAT
JANUARY 10, 2023
In the United States, pharmaceutical advertising seems inescapable. Since the first prescription drug ad ran in the early 1980s, the business of pharmaceutical advertising has exploded. Drug companies spent $7 billion on advertising last year, according to Statista , with most of that going to television ads; more than $287 million was spent on TV advertising for Sanofi and Regeneron’s anti-inflammatory drug Dupixent alone.
Omnicell
JANUARY 10, 2023
Julie O'Brien Director, Product Marketing, Customer Experience, Omnicell The healthcare system is struggling to find a way forward as it works its way through yet another wave of COVID-19. Hospitals are overwhelmed and severely understaffed. As a result, clinicians have been exiting in record numbers. The current situation is not temporary. It's an industry shift that calls for new ways of thinking and working to fight clinician burnout and empower healthcare professionals.
Fierce Healthcare
JANUARY 10, 2023
JPM23: Ascension Health details $2.5B economic recovery plan to rebound from financial, operational headwinds. hlandi. Wed, 01/11/2023 - 00:06.
Omnicell
JANUARY 10, 2023
Len Hom Director, Product Marketing, Omnicell Automated dispensing systems are more than medication vending machines. They’re the foundation of your pharmacy supply chain. More medications are being managed through ADCs than ever before, as health systems are trending toward more decentralized medication distribution models in which medications are stocked at the point of care and are readily accessible to nurses.
STAT
JANUARY 10, 2023
Much of the last decade felt like the golden age of biotechnology investing. Money — lots of money — was poured into new gene therapies that replaced defective genes with healthy ones, immunotherapies that were game changers for people with cancer, innovative medicines for rare diseases and HIV, and more. The returns on biotech stocks were phenomenal.
Expert insights. Personalized for you.
187 
Let's personalize your content